These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 1069300)
41. Insulin receptors in normal and disease states. Grunberger G; Taylor SI; Dons RF; Gorden P Clin Endocrinol Metab; 1983 Mar; 12(1):191-219. PubMed ID: 6342876 [TBL] [Abstract][Full Text] [Related]
42. Insulin activates the appearance of insulin-like growth factor II receptors on the adipocyte cell surface. Oka Y; Mottola C; Oppenheimer CL; Czech MP Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4028-32. PubMed ID: 6330732 [TBL] [Abstract][Full Text] [Related]
43. Deletion of residues 485-599 from the human insulin receptor abolishes antireceptor antibody binding and influences tyrosine kinase activation. Sung CK; Wong KY; Yip CC; Hawley DM; Goldfine ID Mol Endocrinol; 1994 Mar; 8(3):315-24. PubMed ID: 8015549 [TBL] [Abstract][Full Text] [Related]
44. Human autoantibodies directed against the human, but not the rat, insulin receptor. De Pirro R; Rossetti L; Montemurro A; Lauro R; Gammeltoft S; Maddux BA; Goldfine ID J Clin Endocrinol Metab; 1985 Nov; 61(5):986-9. PubMed ID: 4044783 [TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action. Roth RA; Cassell DJ; Wong KY; Maddux BA; Goldfine ID Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7312-6. PubMed ID: 6185950 [TBL] [Abstract][Full Text] [Related]
47. Direct demonstration that receptor crosslinking or aggregation is important in insulin action. Kahn CR; Baird KL; Jarrett DB; Flier JS Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4209-13. PubMed ID: 279910 [TBL] [Abstract][Full Text] [Related]
48. Radioimmunoassay of the insulin receptor: a new probe of receptor structure and function. Harrison LC; Flier J; Itin A; Kahn CR; Roth J Science; 1979 Feb; 203(4380):544-7. PubMed ID: 83675 [TBL] [Abstract][Full Text] [Related]
50. Insulin receptors in isolated human adipocytes. Characterization by photoaffinity labeling and evidence for internalization and cellular processing. Berhanu P; Kolterman OG; Baron A; Tsai P; Olefsky JM; Brandenburg D J Clin Invest; 1983 Dec; 72(6):1958-70. PubMed ID: 6358259 [TBL] [Abstract][Full Text] [Related]
51. Immunological abnormalities in insulin receptors on cultured EBV-transformed lymphocytes from insulin-resistant patient with leprechaunism. Cama A; Marcus-Samuels B; Taylor SI Diabetes; 1988 Jul; 37(7):982-8. PubMed ID: 2454859 [TBL] [Abstract][Full Text] [Related]
52. Structural and immunological characterization of insulin-like growth factor II binding to IM-9 cells. Misra P; Hintz RL; Rosenfeld RG J Clin Endocrinol Metab; 1986 Dec; 63(6):1400-5. PubMed ID: 2946713 [TBL] [Abstract][Full Text] [Related]
53. Hepatic prolactin receptors in the rat: characterization using monoclonal antireceptor antibodies. Katoh M; Raguet S; Zachwieja J; Djiane J; Kelly PA Endocrinology; 1987 Feb; 120(2):739-49. PubMed ID: 3803302 [TBL] [Abstract][Full Text] [Related]
54. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Soos MA; Field CE; Siddle K Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):419-26. PubMed ID: 8452530 [TBL] [Abstract][Full Text] [Related]
55. Functional properties of polyclonal antibodies raised against the N-terminus region (residues 9-30) of the follicle-stimulating hormone (FSH) receptor: significance of this receptor region in FSH recognition and signal transduction. Dattatreyamurty B; Reichert LE Endocrinology; 1993 Oct; 133(4):1593-601. PubMed ID: 8404599 [TBL] [Abstract][Full Text] [Related]
56. Insulin-receptor autoantibody detected by the human placental membrane method: six patients with insulin-receptor autoantibody in japan. Omori Y; Minei S; Saito M; Hirata Y Tohoku J Exp Med; 1982 Nov; 138(3):319-28. PubMed ID: 6760461 [TBL] [Abstract][Full Text] [Related]
57. Insulin resistance and hypoglycemia in a patient with systemic lupus erythematosus: description of antiinsulin receptor antibodies that enhance insulin binding and inhibit insulin action. Di Paolo S; Giorgino R J Clin Endocrinol Metab; 1991 Sep; 73(3):650-7. PubMed ID: 1874939 [TBL] [Abstract][Full Text] [Related]
58. Tissue-specific antibodies against the fibroblast insulin receptor in a patient with lupus nephritis and hypoglycemia. De Pirro R; Borboni P; Lauro R; Festa A; Testa I; De Martinis C; Maddux BA; Goldfine ID Diabetes; 1985 Nov; 34(11):1088-91. PubMed ID: 4043557 [TBL] [Abstract][Full Text] [Related]
59. The immunology of the insulin receptor. Flier JS; Kahn CR; Jarrett DB; Roth J Immunol Commun; 1976; 5(5):361-73. PubMed ID: 786863 [TBL] [Abstract][Full Text] [Related]
60. Interaction of the monoclonal antibodies alpha IR-1 and alpha IR-3 with insulin and somatomedin-C receptors. Jacobs S; Cook S; Svoboda ME; Van Wyk JJ Endocrinology; 1986 Jan; 118(1):223-6. PubMed ID: 2416553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]